Skip to main content
Clinical Trials/NCT02417558
NCT02417558
Completed
Not Applicable

Study to Evaluate the Effectiveness of Personalized Brain Network Activation Technology in a Cognitive/Physical Computer-Game Blended Training of Elderly (Alterniity AR)

XtremeVRI AG0 sites607 target enrollmentFebruary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mild Cognitive Impairment, So Stated
Sponsor
XtremeVRI AG
Enrollment
607
Primary Endpoint
Change in Diagnostic Area Under the Receiver Operating Characteristic Curve (ROC-AUC)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The study involves a novel Virtual Reality Interface that offers full-body immersion "Alterniity AR" and more specifically computer exercises blended with game activities. It was hypothesized that "Alterniity AR" facilitated, game blended cognitive and/or physical exercise improves global cognition when compared to control groups; moreover, these improvements may be manifested by brain activity changes. The investigators explore here the impact of potential moderators on combined exercise-induced cognitive benefits, as well as, individual/separate training schemes.

In addition, the proposed study will provide Alterniity AR" in a closed feedback loop with a direct, reliable, and non-invasive method for assessing changes in brain activity associated with elderly in risk of dementia. The paradigm for the current study will combine neurophysiological knowledge with mathematical signal processing and pattern recognition methods to temporally and spatially map brain function, connectivity and synchronization.

Detailed Description

Currently, there is no direct, reliable, bed-side, and non-invasive method for assessing changes in brain activity associated with elderly in risk of dementia. Event Related Potentials (ERPs), which are temporal reflections of the neural mass electrical activity of cells in specific regions of the brain that occur in response to stimuli, may offer such a method, as they provide both a noninvasive and portable measure of brain function. The ERPs provide excellent temporal information, but spatial resolution for ERPs has traditionally been limited. However, by using high-density electroencephalograph (EEG) recording spatial resolution for ERPs is improved significantly. The proposed study will provide additional evidence for the utility and contribution of a Personalized Brain Network Activation (PBNA) test (reflecting temporal and spatial changes in brain activity as well as brain functional connectivity associated with minor neurocognitive disorder) in early dementia management. The study is conducted in 2 sites: Switzerland and Greece. It uses a pre-post-test design with the between-participant factor group \[intervention(s) vs. passive and/or active control\]. Post-test will be conducted within 2 weeks after completion of the exercise period. Interventions will be carried out within day care centres, hospitals, senior care centres, a memory outpatient centre, local parishes, and at participants' homes. Centres will provide 8-12 exercise weeks per year for 3 years, with a frequency of at least 3 "Alterniity AR" sessions per week, resulting in at least 24-36 intervention sessions each year of the study. The closed feedback loop with a direct PBNA test is basically divided to 3 phases - first EEG data is collected from subjects using a portable EEG system while the participants are performing the "Alterniity AR" intervention. The EEG data is then analysed offline. Finally, the "Alterniity AR" exercise type, configuration and difficulty level is updated based on the analysed data. The Greek site population (n=581) in majority subjects with mild cognitive impairment (MCI) has been described before with Clinical Trial Registration: NCT02313935 The Swiss population (n=126) was 20 healthy controls (HC), 20 mild to moderate Alzheimer's disease (AD) patients, 20 vascular dementia (VAD) patients, 20 fronto-temporal dementia (FTD) patients and 40 subjects with mild cognitive impairment (MCI). This population has been previously described at the following ClinicalTrials.gov Identifier: NCT02050464.

Registry
clinicaltrials.gov
Start Date
February 2015
End Date
December 2018
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
XtremeVRI AG
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • no severe cognitive impairment measured by Mini-Mental State Examination (MMSE) ≥ 18
  • fluent language skills
  • agreement of a medical doctor
  • time commitment to the test and exercise protocol.

Exclusion Criteria

  • concurrent participation in another study
  • severe physical or psychological disorders which precluded participation in the intervention (i.e., inability to follow instructions)
  • unrecovered neurological disorders such as stroke, traumatic brain injury, unstable medication within the past three months
  • severe and uncorrectable vision problems, or hearing aid for less than three months.

Outcomes

Primary Outcomes

Change in Diagnostic Area Under the Receiver Operating Characteristic Curve (ROC-AUC)

Time Frame: baseline to 40 months

The Digital Neuro Signatures (DNS) score will be tested in this prospective cohort. Sensitivity, specificity and accuracy of the DNS score will be tested for detecting intervention responses for both the placebo and the study groups and will be compared to the intervention responses measured by the neuropsychological test battery.

Secondary Outcomes

  • Overall brain function(12 months)
  • Verbal learning and memory as assessed using California Verbal Learning Test (CVLT)(2 months / 6+2 months / 12+2 months)
  • Episodic memory(2 months / 6+2 months / 12+2 months)
  • Working Memory(2 months / 6+2 months / 12+2 months)
  • World Health Organization Quality of Life (WHOQoL)(2 months / 6+2 months / 12+2 months)
  • Verbal short-term memory as assessed using the Digit Span Test(2 months / 6+2 months / 12+2 months)
  • Physical Fitness(2 months / 6+2 months / 12+2 months)
  • Executive Function(2 months / 6+2 months / 12+2 months)
  • Instrumental Activities of daily living(2 months / 6+2 months / 12+2 months)
  • Depressive symptoms(2 months / 6+2 months / 12+2 months)

Similar Trials